Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
The Journal of Pharmacology and Experimental Therapeutics|January 26, 1999
Electrophysiological comparison of 5-Hydroxytryptamine1A receptor antagonists on dorsal raphe cell firingL P Martin, D M Jackson, C Wallsten, et al.
Life Sciences|September 6, 1982
Effects of benzodiazepines on single unit activity in the substantia nigra pars reticulataR J Ross, B L Waszczak, E K Lee, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 1, 1984
Effect of dopamine system activation on substantia nigra pars reticulata output neurons: variable single-unit responses in normal rats and inhibition in 6-hydroxydopamine-lesioned ratsB L Waszczak, E K Lee, C A Tamminga, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 16, 1998
Expression of a dopamine D2 receptor-activated K+ channel on identified striatopallidal and striatonigral neuronsB L Waszczak, L P Martin, G J Greif, et al.
Synapse (New York, N.Y.)|October 6, 2000
Novel in vivo electrophysiological assay for the effects of cocaine and putative "cocaine antagonists" on dopamine transporter activity of substantia nigra and ventral tegmental area dopamine neuronsM A Hinerth, H A Collins, M Baniecki, et al.
Brain Research|July 23, 1984
Single unit responses of substantia nigra pars reticulata neurons to apomorphine: effects of striatal lesions and anesthesiaB L Waszczak, E K Lee, T Ferraro, et al.
European Journal of Pharmacology|November 3, 1994
The putative dopamine D3 receptor agonist 7-OH-DPAT: lack of mesolimbic selectivityJ C Liu, R F Cox, G J Greif, et al.
Brain Research|November 22, 2001
Electrophysiological and behavioral output of the rat basal ganglia after intrastriatal infusion of d-amphetamine: lack of support for the basal ganglia modelB L Waszczak, L Martin, N Boucher, et al.
Neuroscience|July 14, 2015
Intranasal administration of glial-derived neurotrophic factor (GDNF) rapidly and significantly increases whole-brain GDNF level in ratsT S Bender, M M Migliore, R B Campbell, et al.
Neuroscience|May 22, 2014
Neurotrophic and neuroprotective efficacy of intranasal GDNF in a rat model of Parkinson's diseaseM M Migliore, R Ortiz, S Dye, et al.
Pageof 4